Assessing whether one has a genetic predisposition to developing autoimmune diseases allows for the implementation of dietary and supplement strategies with a preventive approach.
Assessing whether one has a genetic predisposition to type 2 diabetes allows for the implementation of dietary and supplement strategies with a preventive focus.
Assessing whether one has a genetic predisposition to fatty liver disease allows for the implementation of dietary and supplement strategies with a preventive focus.
Assessing whether you have a genetic predisposition to obesity allows you to implement dietary and integrative strategies from a preventive perspective.
The protein BAFF (B cell Activating Factor) has been known to the scientific community for well over a decade, and numerous studies have elucidated its involvement in various processes as well as its potential relationships with inflammation, including inflammation related to diet.
For a long time, ESR and CRP have been the primary biomarkers for assessing inflammation. However, these "acute-phase" proteins have limitations in specificity and sensitivity for identifying low-grade inflammation. Other biomarkers, such as BAFF and PAF, which are linked to specific immune pathways, are more accurate for this type of inflammation.
Preventing diabetes by identifying genetic predispositions and lifestyle factors can significantly add healthy years of life. A personalized medicine approach is crucial to enhance quality of life and well-being, allowing occasional indulgences without compromising health.
Inflammation is a physiological process that is, in itself, beneficial and essential for defending the body.
However, various factors—such as dietary imbalances or chronic viral infections—can lead to a persistent, chronic inflammatory state that underlies a wide range of diseases.